MX2025007158A - Inhibidores de gmp?amp sintasa ciclica y sus usos - Google Patents

Inhibidores de gmp?amp sintasa ciclica y sus usos

Info

Publication number
MX2025007158A
MX2025007158A MX2025007158A MX2025007158A MX2025007158A MX 2025007158 A MX2025007158 A MX 2025007158A MX 2025007158 A MX2025007158 A MX 2025007158A MX 2025007158 A MX2025007158 A MX 2025007158A MX 2025007158 A MX2025007158 A MX 2025007158A
Authority
MX
Mexico
Prior art keywords
sup
inhibitors
cyclic gmp
thiadiazole derivatives
amp synthase
Prior art date
Application number
MX2025007158A
Other languages
English (en)
Spanish (es)
Inventor
Ramsay Beveridge
Jason Burch
Stephane Ciblat
Patrick Cyr
Original Assignee
Ventus Therapeutics U S Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ventus Therapeutics U S Inc filed Critical Ventus Therapeutics U S Inc
Publication of MX2025007158A publication Critical patent/MX2025007158A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2025007158A 2022-12-20 2025-06-18 Inhibidores de gmp?amp sintasa ciclica y sus usos MX2025007158A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263433987P 2022-12-20 2022-12-20
US202363501320P 2023-05-10 2023-05-10
PCT/US2023/084787 WO2024137607A1 (en) 2022-12-20 2023-12-19 Thiadiazole derivatives as inhibitors of cyclic gmp-amp synthase and uses thereof

Publications (1)

Publication Number Publication Date
MX2025007158A true MX2025007158A (es) 2025-07-01

Family

ID=89768384

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2025007158A MX2025007158A (es) 2022-12-20 2025-06-18 Inhibidores de gmp?amp sintasa ciclica y sus usos

Country Status (13)

Country Link
US (1) US20240270740A1 (cg-RX-API-DMAC7.html)
EP (1) EP4638446A1 (cg-RX-API-DMAC7.html)
JP (1) JP7870987B2 (cg-RX-API-DMAC7.html)
KR (1) KR20250131845A (cg-RX-API-DMAC7.html)
CN (1) CN120530109A (cg-RX-API-DMAC7.html)
AU (1) AU2023408761A1 (cg-RX-API-DMAC7.html)
CL (1) CL2025001819A1 (cg-RX-API-DMAC7.html)
CO (1) CO2025007987A2 (cg-RX-API-DMAC7.html)
IL (1) IL321525A (cg-RX-API-DMAC7.html)
MX (1) MX2025007158A (cg-RX-API-DMAC7.html)
PE (1) PE20251918A1 (cg-RX-API-DMAC7.html)
TW (1) TW202434205A (cg-RX-API-DMAC7.html)
WO (1) WO2024137607A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026077404A1 (zh) * 2024-10-10 2026-04-16 北京知维拓医药科技有限公司 一种杂环类化合物及其用途
WO2026158338A1 (zh) * 2025-01-22 2026-07-30 北京知维拓医药科技有限公司 一种杂环类化合物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
JP2016506408A (ja) 2012-12-19 2016-03-03 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム 哺乳動物の環状ジヌクレオチドシグナル伝達経路の薬学的標的化
DK3439667T3 (da) * 2016-04-05 2024-04-02 Immune Sensor Llc Cgas antagonist forbindelser
US10738056B2 (en) * 2017-09-15 2020-08-11 Aduro Biotech Inc. Pyrazolopyrimidinone compounds and uses thereof
MX2020008237A (es) 2018-02-05 2020-09-25 Univ Rockefeller Inhibidores de 2,3,4,5-tetrahidro-1h-pirido[4,3-b]indol de cgas para tratar enfermedades autoinflamatorias.
WO2020072492A1 (en) * 2018-10-02 2020-04-09 Baruch S. Blumberg Institute Benzamide derivatives as cgas-sting pathway agonists
JP7781074B2 (ja) * 2020-05-20 2025-12-05 エフ. ホフマン-ラ ロシュ アーゲー Cgas阻害トリアゾロピリミドン誘導体
WO2022137082A1 (en) * 2020-12-22 2022-06-30 Novartis Ag Pyrrolo[3,2-b]pyridine derivatives useful in treating conditions associated with cgas
KR20230124665A (ko) * 2020-12-22 2023-08-25 노파르티스 아게 Cgas 관련 병태의 치료에 유용한 인돌 유도체
EP4778593A2 (en) * 2021-11-08 2026-07-22 Ventus Therapeutics U.S., Inc. Heterocyclic compounds and uses thereof
CN115160279B (zh) * 2022-07-27 2023-11-24 中国药科大学 苯并吡喃酮类化合物、药物组合物和应用

Also Published As

Publication number Publication date
JP7870987B2 (ja) 2026-06-08
AU2023408761A1 (en) 2025-06-19
IL321525A (en) 2025-08-01
PE20251918A1 (es) 2025-08-05
US20240270740A1 (en) 2024-08-15
CO2025007987A2 (es) 2025-09-08
TW202434205A (zh) 2024-09-01
EP4638446A1 (en) 2025-10-29
KR20250131845A (ko) 2025-09-03
CN120530109A (zh) 2025-08-22
WO2024137607A1 (en) 2024-06-27
CL2025001819A1 (es) 2025-09-26
JP2026501225A (ja) 2026-01-14

Similar Documents

Publication Publication Date Title
EP4299135A3 (en) Benzisoxazole sulfonamide derivatives
CR20230310A (es) Inhibidores de prmt5
MX2025001619A (es) Inhibidor de pde4b y uso del mismo
MX2024007058A (es) Derivados de 5,6,7,8-tetrahidro-2,6-naftiridina como terapeuticos contra el cancer.
MX2023002547A (es) Compuestos novedosos como inhibidor de histona desacetilasa 6 y composicion farmaceutica que comprende los mismos.
PH12021552930A1 (en) 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
CR20210602A (es) Compuestos de pirrolidina
MX2020007633A (es) Péptidos macrocíclicos contra acinetobacter baumannii.
NO20051265L (no) Anvendelse av og noen nye imidazopyridiner
PH12023550101A1 (en) Novel compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same
MX2022015886A (es) Derivados de amidopirimidona.
MX2023004033A (es) Espiro derivados de alfa-d-galactopiranosidos.
MX2023002686A (es) Derivados de sulfamoil urea que contienen una porcion alquil-oxacicloalquilo y usos de los mismos.
EP4599892A3 (en) Boronic acid derivatives and therapeutic uses thereof
MX2022013890A (es) Sintesis y derivados de acido boronico, formas polimorficas y usos terapeuticos de los mismos.
MX2023003576A (es) Compuesto como inhibidor de la akt cinasa.
MX2025010952A (es) Derivados de amida para inhibir el gen nlrp3 y usos de los mismos
MY195576A (en) Novel Amino-Imidazopyridine Derivatives as Janus Kinase Inhibitors and Pharmaceutical use Thereof
JOP20220281A1 (ar) مركبات وتركيبات لتثبيط نشاط hif2 ألفا وطرق لاستخدامها
MY133527A (en) Isoquinoline derivatives
WO2025014877A3 (en) Triazolo wrn inhibitors
MX2025010256A (es) Derivados de hidroquinazolina para el tratamiento de una enfermedad o un trastorno
WO2024254511A3 (en) Wrn inhibitors
CO2025007987A2 (es) Derivados de tiadiazol como inhibidores de la sintasa de gmp-amp cíclico y usos de los mismos
MX2024014315A (es) Compuestos amido heteroaromaticos utiles en el tratamiento de enfermedades hepaticas